On Monday the shares of the British giant pharmaceutical company AstraZeneca (LSE:AZN) jumped by nearly 15% to just under 48 pounds a piece, lifting its market capitalisation to just under 60 billion pounds as its U.S. giant rival Pfizer (NYSE: PFE) sweetened its bid price to $101 billion.
The Astrazeneca's shares had a "700 point jump" on its last week's closing prices, which would have netted a profit of 7000 pounds in less than 48 hours, if a long position wager was taken at 10 pound per point on CFD or Spread Betting.
